RITA HENRY: Open Payments
NPI 1700622503 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 58 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,573 · 2025 $1,541
Food & beverage: $1,118Education: $423
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $288 |
| Janssen Biotech, Inc. | 9 | $246 |
| AstraZeneca Pharmaceuticals LP | 9 | $162 |
| Regeneron Healthcare Solutions, Inc. | 4 | $121 |
| Gilead Sciences, Inc. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| ABBVIE INC. | 3 | $64 |
| EMD Serono, Inc. | 3 | $53 |
| Incyte Corporation | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $49 |
Products named: RYBREVANT, TAGRISSO, Trodelvy, LIBTAYO, ERLEADA, MONJUVI, KEYTRUDA, ENHERTU.
Industry payments across NY — which companies pay providers there.
